Concerns about vaccine hesitancy come as childhood vaccination rates are declining, and there is a rise in the so-called ...

A study is seeking to contribute to cancer immunotherapy in the development of vaccines against deadly cancer types such as ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

HPV, one of the most prevalent sexually transmitted infections, is the cause of nearly 36,000 cancer cases each year in the United States.

After several on-again, off-again tariff threats, U.S. President Donald Trump is scheduled later today to announce what is expected to be country-by-country tariffs in an effort to address U.S. trade ...

Greenwich Lifesciences Inc. followed a February update with another on the phase III Flamingo-01 trial, providing open-label immune response data for GLSI-100, a HER2/neu peptide vaccine immunotherapy ...

NEC has developed a system to use face biometrics to authenticate patients for personalized cancer vaccine therapy without ...

The firms hope to show that Verdi's off-the-shelf peptide cancer vaccine can shrink tumors and improve quality of life in patients with bone metastases.

Glenn Moog didn't know much about HPV cancer — until he was diagnosed with it. The 59-year-old husband, father and realtor ...